iScienceMolecular BiologyPeer-reviewed journal article
Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein
Darko BosnakovskiiD, Erik A. TosoiD, Elizabeth T. EneriD, Micah D. GearhartiD, Lulu YiniD, Felipe F. LüttmanniD, Alessandro MagliiD, Ke ShiiD, Johnny KimiD, Hideki AiharaiD, Michael KybaiD
Abstract
Double homeobox (DUX) genes are unique to eutherian mammals and normally expressed transiently during zygotic genome activation. The canonical member, DUX4, is involved in facioscapulohumeral muscular dystrophy (FSHD) and cancer, when misexpressed in other contexts. We evaluate the 3 human DUX genes and the ancestral single homeobox gene sDUX from the non-eutherian mammal, platypus, and find that DUX4 activities are not shared with DUXA or DUXB, which lack transcriptional activation potential, but surprisingly are shared with platypus sDUX. In human myoblasts, platypus sDUX drives cytotoxicity, inhibits myogenesis, and induces DUX4 target genes, particularly those associated with zygotic genome activation (ZGA), by binding DNA as a homodimer in a way that overlaps the DUX4 homeodomain crystal structure. DUXA lacks transcriptional activity but has DNA-binding and chromatin accessibility overlap with DUX4 and sDUX, including on ZGA genes and LTR elements, and can actually be converted into a DUX4-like cytotoxic factor by fusion to a synthetic transactivation domain. DUXA competition antagonizes the activity of DUX4 on its target genes, including in FSHD patient cells. Since DUXA is an early DUX4 target gene, this activity potentiates feedback inhibition, constraining the window of DUX4 activity. The DUX gene family therefore comprises cross-regulating members of opposing function, with implications for their roles in ZGA, FSHD, and cancer. HIGHLIGHTSO_LIPlatypus sDUX is toxic and inhibits myogenic differentiation. C_LIO_LIDUXA targets overlap substantially with those of DUX4. C_LIO_LIDUXA fused to a synthetic transactivation domain acquires DUX4-like toxicity. C_LIO_LIDUXA behaves as a competitive inhibitor of DUX4. C_LI
- organism: human
- organism: plant (other)
- assay: DNA methylation
- assay: proteomics
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 19
- FWCI
- 1.69
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LEUTX mediates amplification of DUX4 signaling and aberrant myotube differentiation in facioscapulohumeral muscular dystrophy
Xiangduk Kong, Sung Jun Beck, … Kyoko Yokomori·bioRxiv·Oct 29, 2026
- In vitro and in silico characterization of competitive inhibition and repression of DUX4 target gene activation as a therapeutic approach for facioscapulohumeral muscular dystrophy (FSHD)
Heloise M. Hoffmann, Alice Finkelstein, … Phillip Kyriakakis·bioRxiv·Aug 20, 2026
- The Interactome of DUX4 Reveals Multiple Activation Pathways
M. Slavin, K. Zohar, … N. Kalisman·bioRxiv·Sep 12, 2023
- Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy
Amelia Fox, Jonathan Oliva, … Francis M. Sverdrup·bioRxiv·May 21, 2024
- P53 is not necessary for DUX4 pathology
Darko Bosnakovski, Micah D. Gearhart, … Michael Kyba·Disease Models & MechanismsPeer-reviewed·Jan 1, 2017
- Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction
Amy E. Spens, Nicholas A. Sutliff, … Stephen J. Tapscott·eLifePeer-reviewed·Apr 24, 2023